ATYR
Price
$5.03
Change
-$0.08 (-1.57%)
Updated
Jun 27 closing price
Capitalization
447.69M
45 days until earnings call
AURA
Price
$6.28
Change
-$0.01 (-0.16%)
Updated
Jun 27 closing price
Capitalization
389.39M
39 days until earnings call
Interact to see
Advertisement

ATYR vs AURA

Header iconATYR vs AURA Comparison
Open Charts ATYR vs AURABanner chart's image
aTyr Pharma
Price$5.03
Change-$0.08 (-1.57%)
Volume$15.79M
Capitalization447.69M
Aura Biosciences
Price$6.28
Change-$0.01 (-0.16%)
Volume$1.31M
Capitalization389.39M
ATYR vs AURA Comparison Chart in %
Loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATYR vs. AURA commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a Hold and AURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (ATYR: $5.03 vs. AURA: $6.28)
Brand notoriety: ATYR and AURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 715% vs. AURA: 557%
Market capitalization -- ATYR: $447.69M vs. AURA: $389.39M
ATYR [@Biotechnology] is valued at $447.69M. AURA’s [@Biotechnology] market capitalization is $389.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green whileAURA’s FA Score has 0 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • AURA’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 4 TA indicator(s) are bullish while AURA’s TA Score has 3 bullish TA indicator(s).

  • ATYR’s TA Score: 4 bullish, 3 bearish.
  • AURA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ATYR is a better buy in the short-term than AURA.

Price Growth

ATYR (@Biotechnology) experienced а -3.64% price change this week, while AURA (@Biotechnology) price change was +3.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ATYR is expected to report earnings on Aug 13, 2025.

AURA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATYR($448M) has a higher market cap than AURA($389M). ATYR YTD gains are higher at: 38.950 vs. AURA (-23.601). ATYR has higher annual earnings (EBITDA): -65.9M vs. AURA (-101.63M). AURA has more cash in the bank: 128M vs. ATYR (76.3M). ATYR has less debt than AURA: ATYR (13M) vs AURA (18.4M). ATYR (0) and AURA (0) have equivalent revenues.
ATYRAURAATYR / AURA
Capitalization448M389M115%
EBITDA-65.9M-101.63M65%
Gain YTD38.950-23.601-165%
P/E RatioN/AN/A-
Revenue00-
Total Cash76.3M128M60%
Total Debt13M18.4M71%
FUNDAMENTALS RATINGS
ATYR: Fundamental Ratings
ATYR
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
39

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATYRAURA
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AQEAX15.030.09
+0.60%
Columbia Disciplined Core A
VBCVX15.180.05
+0.33%
VALIC Company I Systematic Value
FLIIX12.03N/A
N/A
First Sentier Global Listed Infras I
IAFEX13.79N/A
N/A
FI Instl Grp All Frgn Eq Env & Scl Val
KNPYX136.35-1.67
-1.21%
Kinetics Paradigm Instl

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with MGTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
-1.57%
MGTX - ATYR
44%
Loosely correlated
-0.90%
RZLT - ATYR
43%
Loosely correlated
+0.93%
AURA - ATYR
41%
Loosely correlated
-0.16%
SLDB - ATYR
40%
Loosely correlated
-1.87%
IDYA - ATYR
38%
Loosely correlated
-4.13%
More

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with MGTX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-0.16%
MGTX - AURA
53%
Loosely correlated
-0.90%
VRDN - AURA
51%
Loosely correlated
-1.37%
IDYA - AURA
51%
Loosely correlated
-4.13%
BEAM - AURA
50%
Loosely correlated
-1.98%
CCCC - AURA
48%
Loosely correlated
-7.89%
More